0.7256
price down icon1.79%   -0.0132
after-market アフターアワーズ: .71 -0.0156 -2.15%
loading

Oncolytics Biotech Inc (ONCY) 最新ニュース

pulisher
Feb 20, 2025

Oncolytics Biotech Inc. (NASDAQ:ONCY) Sees Significant Increase in Short Interest - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Investors Eye Biotech Sector as Cancer Therapy Market Surges - KamloopsBCNow

Feb 20, 2025
pulisher
Feb 20, 2025

Oncolytics Biotech Inc - MENAFN.COM

Feb 20, 2025
pulisher
Feb 19, 2025

Oncolytics Biotech advances pancreatic, anal cancer trials - TipRanks

Feb 19, 2025
pulisher
Feb 19, 2025

USA News Group: Investors Eye Biotech Sector as Cancer Therapy Market Surges - FinanzNachrichten.de

Feb 19, 2025
pulisher
Feb 19, 2025

This AI Stock Is Up 50% in 2025. Is It Too Late to Buy? - The Globe and Mail

Feb 19, 2025
pulisher
Feb 19, 2025

Canadian Tire Corporation announces sale of Helly Hansen to Kontoor Brands; simplifying CTC portfolio to focus on Canadian retail growth - The Globe and Mail

Feb 19, 2025
pulisher
Feb 19, 2025

Oncolytics Biotech Advances Cancer Trials, Strengthening 2025 Pipeline - TipRanks

Feb 19, 2025
pulisher
Feb 19, 2025

Can This Dual Cancer Trial Success Transform Oncolytics' Market Position? - StockTitan

Feb 19, 2025
pulisher
Feb 19, 2025

Prediction: Zoom Will Struggle to Beat the Market. Here's Why - The Globe and Mail

Feb 19, 2025
pulisher
Feb 18, 2025

Oncolytics Biotech advances in cancer immunotherapy trials By Investing.com - Investing.com Canada

Feb 18, 2025
pulisher
Feb 18, 2025

Oncolytics Biotech advances in cancer immunotherapy trials - Investing.com

Feb 18, 2025
pulisher
Feb 18, 2025

Clinical Trial Success: Oncolytics' Cancer Drug Shows Superior Results in Two Major Cancer Types - StockTitan

Feb 18, 2025
pulisher
Feb 18, 2025

Optimism in War on Cancer on the Rise, as Biotech Companies Roll Out More Wins - Financial Content

Feb 18, 2025
pulisher
Feb 18, 2025

Oncolytics Biotech Advances Cancer Treatment Pipeline with Key 2025 Developments - TipRanks

Feb 18, 2025
pulisher
Feb 18, 2025

Clinical Breakthrough: Oncolytics' Cancer Drug Shows Remarkable Results in Three Major Cancer Types - StockTitan

Feb 18, 2025
pulisher
Feb 18, 2025

Oncolytics Biotech Gets Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency - Marketscreener.com

Feb 18, 2025
pulisher
Feb 17, 2025

A closer look at Inhibrx Biosciences Inc (INBX)’s stock price trends - US Post News

Feb 17, 2025
pulisher
Feb 17, 2025

Pan American Silver Stock Forecast: Q4 2024 Earnings Preview - The Globe and Mail

Feb 17, 2025
pulisher
Feb 14, 2025

Oncolytics Biotech receives Nasdaq non-compliance notice - MSN

Feb 14, 2025
pulisher
Feb 14, 2025

Oncolytics Biotech faces Nasdaq delisting over share price - MSN

Feb 14, 2025
pulisher
Feb 14, 2025

Oncolytics Biotech® Announces Receipt of Nasdaq Notification Let - GuruFocus.com

Feb 14, 2025
pulisher
Feb 14, 2025

Oncolytics Biotech Receives Nasdaq Notification for Bid Price Deficiency - TipRanks

Feb 14, 2025
pulisher
Feb 14, 2025

Nasdaq Issues Warning: Oncolytics Biotech Faces Critical 6-Month Deadline to Avoid Delisting - StockTitan

Feb 14, 2025
pulisher
Feb 13, 2025

Oncolytics Biotech Announces Leadership Change Amid CEO’s Health Concerns - TipRanks

Feb 13, 2025
pulisher
Feb 13, 2025

AMC Networks (AMCX) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail

Feb 13, 2025
pulisher
Feb 12, 2025

Oncolytic Virus Therapy Market Growth, Innovations, Demand & - openPR

Feb 12, 2025
pulisher
Feb 11, 2025

IGC Pharma Expands Into $75 Billion Wellness Market with the Launch of Holiby(TM) - The Globe and Mail

Feb 11, 2025
pulisher
Feb 10, 2025

Oncolytics Biotech Announces Leadership Change Amid CEO Departure - TipRanks

Feb 10, 2025
pulisher
Feb 09, 2025

Oncolytics Biotech (TSE:ONC) Shares Up 2.9%Time to Buy? - MarketBeat

Feb 09, 2025
pulisher
Feb 08, 2025

Oncolytics Biotech (TSE:ONC) Sets New 1-Year LowHere's Why - MarketBeat

Feb 08, 2025
pulisher
Feb 08, 2025

What is HC Wainwright's Estimate for ONCY FY2024 Earnings? - MarketBeat

Feb 08, 2025
pulisher
Feb 07, 2025

Oncolytics Biotech® Announces Matt Coffey, Ph.D. Will Not Return to CEO Role Following Medical Leave of Absence - Lelezard

Feb 07, 2025
pulisher
Feb 07, 2025

Oncolytics Biotech's Co-Founder CEO Exits: Critical Leadership Change Amid Cancer Drug Development - StockTitan

Feb 07, 2025
pulisher
Feb 07, 2025

ONCYOncolytics Biotech, Inc. Common Shares Latest Stock News & Market Updates - StockTitan

Feb 07, 2025
pulisher
Feb 07, 2025

Oncolytics Biotech And 2 Other Promising Penny Stocks On The TSX - Simply Wall St

Feb 07, 2025
pulisher
Feb 07, 2025

Pre-Op Immunotherapy May Help Treat Aggressive Breast Cancers - 69News WFMZ-TV

Feb 07, 2025
pulisher
Feb 07, 2025

FY2029 Earnings Estimate for TSE:ONC Issued By HC Wainwright - MarketBeat

Feb 07, 2025
pulisher
Feb 06, 2025

Equities Analysts Offer Predictions for ONCY FY2024 Earnings - Defense World

Feb 06, 2025
pulisher
Feb 05, 2025

Oncolytics Biotech (ONCY) Upgraded to Buy: What Does It Mean for the Stock? - MSN

Feb 05, 2025
pulisher
Feb 05, 2025

H.C. Wainwright maintains $5 target on Oncolytics Biotech stock - MSN

Feb 05, 2025
pulisher
Feb 05, 2025

Can you now get a good deal on Oncolytics Biotech, Inc’s shares? - US Post News

Feb 05, 2025
pulisher
Feb 05, 2025

FY2029 Earnings Forecast for ONCY Issued By HC Wainwright - Defense World

Feb 05, 2025
pulisher
Feb 05, 2025

FY2029 Earnings Forecast for TSE:ONC Issued By HC Wainwright - Defense World

Feb 05, 2025
pulisher
Feb 05, 2025

Oncolytics Biotech (NASDAQ:ONCY) Earns “Buy” Rating from HC Wainwright - Defense World

Feb 05, 2025
pulisher
Feb 04, 2025

Financial Metrics Exploration: Understanding Oncolytics Biotech, Inc (ONCY) Through Ratios - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Brokers Offer Predictions for ONCY FY2029 Earnings - MarketBeat

Feb 04, 2025
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
大文字化:     |  ボリューム (24 時間):